INTENSITY THERAPEUTICS Director Mark A. Goldberg Receives 5,500-Share Award

What Happened

• Mark A. Goldberg, a director of Intensity Therapeutics, Inc. (INTS), was granted 5,500 derivative shares (reported as an award/acquisition) on July 16, 2026. The reported acquisition price was $0.00 (no cash paid). The Form 4 reporting this grant was filed on July 20, 2026.
• This is a compensation grant (award) to a director rather than an open-market purchase or sale.

Key Details

• Transaction date: July 16, 2026; Form 4 filed: July 20, 2026.
• Transaction type/code: Grant/Award (A); 5,500 derivative shares reported at $0.00 per share.
• Vesting: Per the filing footnote, the award vests in four equal annual installments, beginning July 16, 2026, subject to continued service.
• Shares owned after transaction: Not disclosed in the provided excerpt.
• No 10b5-1 plan, tax-withholding sale, or immediate sale of shares noted in the provided data.
• Timeliness: Filing date is shown as July 20, 2026; check original filing for a timeliness flag (not provided here).

Context

• This is a typical equity-based director compensation award that vests over time. It is a derivative/award grant, not an immediate purchase or sale of stock, so it does not by itself indicate a near-term trading signal.